Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
Trials. 2024 Apr 19;25(1):272. doi: 10.1186/s13063-024-08114-9.
Children with sensitization against foods have to be orally food-challenged before eating these foods for the first time. However, the waiting time for an oral food challenge (OFC) in Germany is about 3-6 months. In contrast, there are hints that an early introduction of allergenic foods might be protective regarding the development of food allergy. The aim of this clinical trial is therefore to investigate, whether an introduction and regular consumption of small amounts of food allergens is safe and will result in an increase of tolerance in children with sensitization against food allergens with unknown clinical relevance.
In this randomized, placebo-controlled, double-blind, single-center trial, 138 children (8 months to 4 years of age) sensitized to the target allergen(s) hen's egg, cow's milk, peanuts, and/or hazelnuts with unknown clinical relevance will be randomized in a 1:1 ratio to either an active or a placebo group, daily receiving a rusk-like biscuit powder with or without the target allergen(s) for 3-6 months until an OFC will be performed in routine diagnostics. The primary endpoint is an IgE-mediated food allergy to the primary target allergen, after the interventional period.
Children with sensitization against food allergens with unknown clinical relevance often have to avoid the corresponding foods for several months until an OFC is performed. Therefore, the "window of opportunity" for an early preventive introduction of allergenic foods might be missed. This trial will assess whether an introduction of small allergen amounts will favor tolerance development in these children.
German Clinical Trials Register DRKS00032769. Registered on 02 October 2023.
儿童对食物过敏时,在首次食用这些食物前必须进行口服食物挑战。然而,在德国,进行口服食物挑战(OFC)的等待时间约为 3-6 个月。相比之下,有迹象表明早期引入过敏原食物可能对预防食物过敏的发展具有保护作用。因此,本临床试验旨在研究,对于致敏但临床意义未知的食物过敏原的儿童,引入和定期食用少量食物过敏原是否安全,并会导致其对过敏原的耐受性增加。
在这项随机、安慰剂对照、双盲、单中心试验中,将 138 名(8 个月至 4 岁)对目标过敏原(鸡蛋、牛奶、花生和/或榛子)致敏但临床意义未知的儿童以 1:1 的比例随机分为活性组或安慰剂组,每天接受含有或不含有目标过敏原的脆饼样饼干粉 3-6 个月,直到在常规诊断中进行 OFC。主要终点是在干预期后,对主要目标过敏原发生 IgE 介导的食物过敏。
致敏但临床意义未知的食物过敏儿童通常需要避免相应的食物几个月,直到进行 OFC。因此,早期预防性引入过敏原食物的“机会之窗”可能会错过。本试验将评估引入小量过敏原是否有利于这些儿童的耐受发展。
德国临床试验注册中心 DRKS00032769。注册于 2023 年 10 月 2 日。